InvestorsHub Logo
Followers 67
Posts 1297
Boards Moderated 0
Alias Born 08/12/2014

Re: None

Tuesday, 07/21/2020 11:27:29 AM

Tuesday, July 21, 2020 11:27:29 AM

Post# of 703710
My only recommendation to longs if I may is that one should have drawn a line where a successful trial is clearly marked with data:

My line to put it simple is this: judged by risk/benefit ratio the FDA ponders when it makes decision on approve or not approve a drug or a biological agent or something in between, DCVax-L trial will be successful as long as there is demonstrated separations between either of the standard care arm and the treatment arm, the early and later vaccined arms, the intended to treat patients and comparable historical standard care data (as FDA's recent guideline suggests), specified patient groups with clearly specified biomarks as we already know DCVax-L is safe.

Nobody should or dare to decline to approval a vaccine which is SAFE and somewhat effective, having a good quality of life indication, and tailored for self treatment from one's own cell, let alone I strongly believe DCVax-L trial will show strong treatment effects.

so that to draw another line of trading/investment/buy or sell when topline data is announced: a line marked by reasonable market cap, either it is 3 billions or 20 billions, a line where below it it's time to buy regardless what the share price will be and believe it will be temporary, and the market will live to its law to reflect a rational and reasonable share price (market cap to be exact).

The shorts have put our lives in misery for so long and more importantly have potentially harm so many patients on their track of destruction, when the time comes, we ought to grab/compete away as many as possible shares from the terrified shorts mouths, and let them pay.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News